Software - ANVISA Registration 82167460004
Access comprehensive regulatory information for Software in Brazil's medical device market through Pure Global AI's free database. This Risk Class I medical device is registered under ANVISA number 82167460004 and manufactured by MIM FERTILITY SP. Z O.O.. The registration is held by IVF BRASIL SOLUCOES LABORATORIAIS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including PHILIPS MEDICAL SYSTEMS NEDERLAND B.V., CARDIO SISTEMAS COMERCIAL E INDUSTRIAL LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
82167460004
25351048256202513
36367739000183
Company Information
Dates and Status
Apr 28, 2025
VIGENTE
09/18/2025 19:00:01
Software
Future Fertility Oocyte Software
FUTURE FERTILITY INC.
83084440002
Aug 18, 2025
Software
Future Fertility Oocyte Software
FUTURE FERTILITY INC.
81504790393
Apr 01, 2024
SOFTWARE FOR MEDICAL IMAGE PROCESSING
EMATM
AIVF LTD
80102513124
Nov 20, 2023
Software
ENDOSIZE
THERENVA SAS
80117580597
Oct 02, 2017
Software
ASTRAIA
NEXUS/ASTRAIA GMBH
80778229001
Jan 12, 2015
Software
Calculadora VDZ-CDST
TAKEDA PHARMACEUTICALS U.S.A., INC.
80147410026
Sep 15, 2025
Software
P4C
DEDALUS ITALIA SPA
81806320006
Sep 15, 2025
Software
AFOOT AI
LOOKINSIDE SERVICOS E TECNOLOGIAS LTDA
83126510001
Sep 08, 2025
Software
MV PEP
MV SISTEMAS DE MEDICINA DIAGNOSTICA LTDA
80436840006
Sep 08, 2025
Software
Future Fertility Oocyte Software
FUTURE FERTILITY INC.
83084440002
Aug 18, 2025